Litcius/Paper detail

Combining phages and antibiotic to enhance antibiofilm efficacy against an in vitro dual species wound biofilm

Ergun Akturk, Luís D. R. Melo, Hugo Oliveira, Aurélie Crabbé, Tom Coenye, Joana Azeredo

2023Biofilm50 citationsDOIOpen Access PDF

Abstract

, which are the prevailing bacterial species that co-infect chronic wounds. Phage therapy has gained an increased interest to treat biofilm-associated infections, namely when combined with antibiotics. Here, we tested the effect of gentamicin as a co-adjuvant of phages in a dual species-biofilm wound model formed on artificial dermis. The biofilm-killing capacity of the tested treatments was significantly increased when phages were combined with gentamicin and applied multiple times as multiple dose (three doses, every 8 h). Our results suggest that gentamycin is an effective adjuvant of phage therapy particularly when applied simultaneously with phages and in three consecutive doses. The multiple and simultaneous dose treatment seems to be essential to avoid bacterial resistance development to each of the antimicrobial agents.

Topics & Concepts

BiofilmMicrobiologyPseudomonas aeruginosaGentamicinStaphylococcus aureusAntibioticsAntimicrobialAdjuvantChronic woundBiologyDermisIn vitroBacteriaWound healingChemistryImmunologyAnatomyBiochemistryGeneticsBacteriophages and microbial interactionsMicrobial infections and disease researchRabies epidemiology and control